DS

Dipal Shantilal Shah

Director Director DIN 01512789
DIN 01512789 First appointment May 1996 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since May 1996
Shareholding value β€’β€’β€’β€’ Premium profile

About Dipal Shantilal Shah

Data last updated:

Dipal Shantilal Shah has 30 years in corporate governance. Formerly with 1 company, such as Zorex Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01512789
Primary Designation Director
First Appointment 13 May 1996
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zorex Pharma Private Limited U24231GJ1996PTC029593
Director13 May 19961996₹2.32 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zorex Pharma Private Limited
Premium access

Shareholding and investment profile for Dipal Shantilal Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dipal Shantilal Shah

Dipal Shantilal Shah has 30 years in corporate governance. Formerly with 1 company, such as Zorex Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Dipal Shantilal Shah has expertise in General Business.

Dipal Shantilal Shah has 30 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available